MoonLake Immunotherapeutics Working Capital to Net Assets Ratio

Latest as of March 2026: 138.0%

MoonLake Immunotherapeutics working capital to net assets ratio. MoonLake Immunotherapeutics (MLTX) has a Working Capital to Net Assets ratio of 138.0% as of March 2026. Working capital of $350.53 Million (current assets of $396.64 Million minus current liabilities of $46.11 Million) is measured against net assets of $254.02 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check MLTX tangible net assets ratio to evaluate the tangible quality of the company's equity base.

WC/NA Ratio

138.0%
Working Capital / Net Assets

Working Capital

$350.53 Million
USD

Current Assets

$396.64 Million
USD

Current Liabilities

$46.11 Million
USD

Working Capital to Net Assets Ratio of MoonLake Immunotherapeutics (2020–2025)

Working capital to net assets ratio of MoonLake Immunotherapeutics from 2020 to 2025. This chart shows how MoonLake Immunotherapeutics's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2020 to 2025. As of March 2026, the ratio stands at 138.0%, reflecting working capital of $350.53 Million against net assets of $254.02 Million USD. See MLTX cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

MoonLake Immunotherapeutics Working Capital to Net Assets Ratio by Year (2020–2025)

MoonLake Immunotherapeutics working capital to net assets ratio by year from 2020 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for MoonLake Immunotherapeutics from 2020 to 2025, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of MoonLake Immunotherapeutics.

Year WC/NA Ratio Working Capital (USD) Net Assets Current Assets Current Liabilities Change (pp)
2025 123.6% $376.22 Million $304.48 Million $421.69 Million $45.48 Million ▲ +23.9 pp
2024 99.7% $451.82 Million $453.39 Million $474.29 Million $22.46 Million ▲ +1.5 pp
2023 98.2% $504.20 Million $513.49 Million $514.17 Million $9.97 Million ▼ -1.9 pp
2022 100.1% $68.85 Million $68.77 Million $76.51 Million $7.67 Million ▲ +1.8 pp
2021 98.3% $-11.45 Million $-11.65 Million $9.64 Million $21.09 Million ▲ +97.0 pp
2020 1.3% $1.49 Million $112.48 Million $1.62 Million $125.18K —
pp = percentage points